CHANGES IN CLEARANCE OF ANTIEPILEPTIC DRUGS DURING PUBERTY NIH GUIDE, Volume 25, Number 3, February 9, 1996 RFP AVAILABLE: NIH-NINDS-96-05 P.T. 34 Keywords: Anticonvulsants Bioassay Clinical Medicine, General National Institute of Neurological Disorders and Stroke The National Institute of Neurological Disorders and Stroke (NINDS), NIH will solicit proposals for performance of an observational study that will use a cross-sectional design to investigate the clearance of antiepileptic drugs (phenytoin, carbamazepine, valproate, and lamotrigine) in male and female patients during age ranges that will include pre-, peri-, and post-pubertal stages. Offerors are required to have an existing, appropriate laboratory for assay of antiepileptic drugs in blood or plasma. Performance of work under this project will require an offeror to have access to a patient population sufficient to enroll and complete a target number of 64 patients being medically treated for epilepsy at their site. Offerors shall have personnel on staff with established clinical expertise in the treatment of epilepsy and experience in evaluating and recruiting suitable patients. It is anticipated that up to 10 contracts will be awarded for a maximum period of 21 months each. Payment will be on a cost-reimbursement basis for the three-month preparation phase and on a fixed price per patient basis for the eighteen-month study conduct phase. INQUIRIES This is not a Request for Proposals (RFP). RFP No. NIH-NINDS-96-05 will be issued on or about February 5, 1996. Proposals will be due approximately sixty days after issuance of the RFP. All responsible sources may submit a proposal that will be considered by the NINDS. To receive a copy of the RFP, submit a written request and two self-addressed mailing labels to: Raina Cervantes Contracts Management Branch National Institute of Neurological Disorders and Stroke Federal Building, Room 901 7550 Wisconsin Avenue, MSC 9190 Bethesda, MD 20892-9190 Reference: RFP No. NIH-NINDS-96-05 .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |